Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dexing Zhongke Fine Chemical is a Chinese fine chemical manufacturer focused on methyl-series chemicals and intermediates used in pharmaceuticals, pesticides, organic synthesis, and related industrial applications. The company appears to operate primarily as a commercial manufacturer rather than a drug developer, with reported production and R&D capabilities and exports to Japan, the United States, Europe, and other markets. Publicly listed product lines include methanesulfonyl chloride, methanesulfonamide, methanesulfonic acid, methanesulfonic anhydride, stannous methanesulfonate, ethyl trifluoroacetoacetate, and N-methyl pyrrolidine. Available sources indicate that its pharmaceutical relevance is mainly through supply of medicine intermediates rather than ownership of a therapeutic pipeline. The company therefore fits better as a specialty chemical and intermediate supplier serving life science and industrial value chains than as a biotech or innovative pharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhongke Fine Chemical.